Pfizer Inc recently announced the discontinuation of a Phase III study of its investigational agent Axitinib for the treatment of advanced pancreatic cancer...
LONDON, Feb 23 - An experimental drug that makes cancer cells susceptible to a widely used treatment could help women with a hard-to-treat and often more aggressive form of breast cancer, researchers said on Monday....
Cryo-Save Group recently announced the launch of its India operations through its 100 per cent subsidiary, Cryo-Save India. The Indian subsidiary has been set up with...
鈥ays Sanjeev Saxena, chairman&chief promoter, Actis Biologics Group of Companies as he describes emerging opportunities in the biotech industry...
A new approach to the treatment of pain, inflammation and fever has been developed in Germany using chemical substances belonging to the dual mPGES-1/5-LO-Inhibitors...
Celsion recently developed ThermoDox drug delivery platform, which uses heat-activated liposomes that break down above a certain temperature...
Roche 454 Life Sciences recently announced that a team of researchers have used the Genome Sequencer FLX system to monitor low-frequency HIV variants from...
When Ken Poteete was the CEO for Georgetown Healthcare System, the health care provider upgraded from a .5T to a 1.5T. Even though the equipment was upgraded...
LEADING oncologists have called for cancer treatments to be independently reviewed to ensure toxic and expensive drugs are not being overused at patients' and taxpayers' expense...
Colorado - A treatment for heart attack victims that may some day rank among CPR and defibrillating paddles as one of the most effective ways to help people survive will ...